Furthermore, it has been suggested that COVID‐19 disease severity reflects imbalanced effects of Ang II/AT‐1 and Ang 1‐7/Mas‐R at tissue level, promoting vasoconstriction, inflammation and coagulopathy. This evidence concerns the gene ANGPT1 and COVID-19.